...
首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >Position statement: Nonanesthesiologist administration of propofol for GI endoscopy.
【24h】

Position statement: Nonanesthesiologist administration of propofol for GI endoscopy.

机译:立场声明:非麻醉医师在胃肠道内镜下使用异丙酚。

获取原文
获取原文并翻译 | 示例
           

摘要

This statement on the use of nonanesthesiologist-adminis-tered propofol (NAAP) for GI endoscopy is issued jointly by The American Association for the Study of Liver Diseases, American College of Gastroenterology, American Gastroen-terological Association, and American Society for Gastrointestinal Endoscopy. A 4-memb.er committee, composed of a representative from each society, prepared the first draft of this document, which was then reviewed and approved by the governing board of each organization. This document is designed to provide an evidence-based assessment ofpropofol-mediated sedation by properly trained gastroenterologists and other nonanesthesiologists
机译:由美国肝病研究协会,美国胃肠病学院,美国胃肠病学协会和美国胃肠内镜协会联合发表的有关使用非麻醉药管理的异丙酚(NAAP)进行胃肠道内窥镜检查的声明。由来自每个社会的代表组成的4人委员会准备了该文件的初稿,然后由每个组织的理事会进行审核和批准。本文件旨在通过受过良好训练的肠胃病医师和其他非麻醉医师对丙泊酚介导的镇静作用进行循证评估

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号